AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY.
Auteurs principaux: | , , , , , , , , |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Elsevier
2023-10-01
|
Collection: | IBRO Neuroscience Reports |
Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S2667242123010126 |